Intraurethral application of prostaglandin-E1 (MUSEt) is a well-tolerated pharmacotherapy for erectile dysfunction. However, the physiological mechanisms of drug transfer into the cavernous bodies are not completely clear. Using spongiosography in 35 patients, our study tried to elucidate existing shunt mechanisms. The X-rays show venous drainage through the deep dorsal vein up to the plexus Santorini. The circumflex veins are also contrasted and the cavernous bodies show opacification in their distal portion only. Structures shunting directly between the corpus spongiosum and the cavernous bodies were not demonstrable. Retrograde filling of the cavernous bodies through the deep dorsal vein and its circumflex braches seems to be the most relevant way of drug transfer after intraurethral application of prostaglandin-E1. Diffusion into the cavernous bodies or a systemic mechanism of action does not seem probable.
Introduction
Until the introduction of sildenafil, intracavernosal injection pharmacotherapy (ICI) was considered to be the gold standard of pharmacological treatment for erectile dysfunction for more than 15y. 1 Prostaglandin-E1 (PGE1) is still the therapy of choice in patients not responding to oral drug therapy or with contraindications for oral agents. 1 The risk of side effects is low. Priapism is rare, occurring in less than 1% of cases of self-administration. 2 The risk of intracavernosal fibrosis is low, at 1-5%. 1, [3] [4] [5] In the attempt to develop a more comfortable and needle-free method of administering active compounds to induce penile erection, the intraurethral application of alprostadil 'Medicated Urethral System for Erection' (MUSEt) was introduced in 1994. 6 With this method, a pellet of PGE1 with a dosage up to 1000 mg is inserted into the distal urethra. A total of 37-60% of all patients show an erection sufficient for sexual intercourse. 2, 7 Considering the dropout rate from ICI of at least 25%, MUSEt may be a reliable and satisfying therapeutic alternative. 8 MUSEt is considered to be more an intercourse facilitator than an erection inducer, [8] [9] [10] especially for patients with psychogenic, neurogenic or mild vasculogenic impotence, who show the best response. 7, 11, 12 The intraurethral application is well tolerated, 7, 9, [13] [14] [15] and the quality of life increases significantly for patients and their partnerships. 14, 16, 17 From the pharmacological point of view, the drug transfer mechanisms from the urethra into the cavernous bodies have not been completely ascertained. Diffusion from the corpus spongiosum to the corpora cavernosa, 11 retrograde drug transfer through the deep dorsal vein and its circumflex branches, 18, 19 and direct connections between the corpus spongiosum and the cavernous bodies through communicating vessels 20, 21 are under discussion. The purpose of our study was to depict, by means of spongiosography, any shunt mechanisms between the different structures of the human penis that could explain possible hemodynamic pathways of MUSE.
Materials and methods
A total of 35 patients aged 35-73 y and suffering from urethral stricture underwent spongiosography, primarily to estimate the extent of a spongiosal fibrosis. Reading these pictures retrospectively, an attempt was made to detect signs of possible transfer mechanisms between the corpus spongiosum and the cavernous bodies of the penis.
The examination took place under sterile conditions, with patients in a supine position. A 22-gauge butterfly needle was placed into the glans penis close to the frenulum. The right thigh was drawn up to a 901 angle and the penis was stretched along the axis of the right thigh. Non-ionic urography contrast medium (300 mg J/ml iopromidet) was injected slowly until complete opacification of the corpus spongiosum was achieved. X-rays were made of the anteroposterior and right posterior oblique views. At the end of the examination, the needle was removed, and manual compression of the glans penis was maintained for at least 2 min to prevent hematoma.
Results
The examination was well tolerated by all patients, and no side effects or complications were encountered. Complete opacification of the spongy tissue was obtained in every patient. Injection time averaged 41 s, and the necessary amount of contrast medium was 18 ml.
The conducted spongiosographies revealed the shape of the glans penis, the corpus spongiosum up to the membranous portion of the urethra and the paths of venous drainage (Figure 1 ). The corpus spongiosum of the penis drains into the superficial dorsal veins and the deep dorsal vein. The blood flows via bulbar venous retes to the prostatic plexus and to the internal pudendal vein. The deep dorsal vein (Figures 1 and 2, arrows) , its mainly distally localized circumflex branches (Figure 2 , arrowheads) and Santorini's plexus (Figure 1 ) are depicted well. An opacification of the cavernous bodies of penis, as a sign of collateral drainage, is achieved only in the distal portion of the penis (Figure 2 ). In only one case ( Figure 3 ) the cavernous bodies did fill completely with contrast medium up to the crura of the penis. No vessels communicating directly between the corpus spongiosum and the cavernous bodies were revealed.
Discussion
For topical medication in erectile dysfunction, the urethra seems to provide the most effective passage to the cavernous bodies. 19 A dosage of 80% of intraurethrally applied PGE1 is resorbed within 10 min. The intraspongeal drug level increases rapidly with an absorption half-life of 2.4 min. 
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T Bschleipfer et al However, the drug transfer process from the spongiosal body into the cavernous bodies is not completely clear. Direct diffusion does not seem to be the most relevant means of drug transfer, given the long path through the fibrous coat of the cavernous bodies. The concentration of active agent reaching the cavernous bodies by diffusion is not sufficiently high to cause an erection adequate for sexual intercourse. 23 Direct diffusion might only serve for additional or supporting drug transfer.
Owing to the high pulmonary first pass effect, a systemic mechanism of action after venous drainage of the drug can also be disregarded. 24 The intraurethral pellet contains a 25-to 100-fold higher dosage in comparison with the intracavernosal injection, but in case of a systemic mechanism, systemic side effects would be seen more often than described in the literature. 2, 9, 14, 15 Intraspongiosal and intracavernosal injections of PGE1 show a similar delay to cavernosal reaction. 19 The drug transfer between the corpus spongiosum and the cavernous bodies must therefore be accomplished by anatomical structures. Vascular channels communicating between the corpus spongiosum and the cavernous bodies 20, 21 or a retrograde filling of the cavernous bodies through the deep dorsal vein and its circumflex branches 18, 19 have been taken into consideration. Besides the transport of drugs only, vasodilatation of the cavernous bodies can also be caused by a neural reflex following vasodilatation of the spongy body or by vascular channels that conduct the impulse for smooth muscle relaxation by their endothelial and smooth muscle cell connections. 13 After intraurethral application of 500 mg PGE1, one study demonstrates the existence of communicating arterial and venous vessels as direct connections between the corpus spongiosum and the cavernous bodies by means of duplex ultrasound. 20 These structures could also be shown by the preparation of corrosion casts of human penises, 21 but have not been revealed by any spongiosography 19 as in our study. The small internal diameter of these structures might be one reason for their escaping detection, especially when performing spongiosography without applying intraurethral or intraspongiosal PGE1, and thus without any vasodilatation. A second reason might be the fact that intraurethral or transglandular application of PGE1 increases the intraspongiosal pressure, with a difference in pressure between the corpus spongiosum and the cavernous bodies. 19, 20 This might open these direct shunting vessels that cannot be depicted merely by the use of contrast medium at equal pressure in the different compartments of the penis. A spongiosography after intraurethral or intraspongiosal application of PGE1 has not been described in the literature until now but could probably provide further information.
Our spongiosographies demonstrated a venous drainage through the deep dorsal vein and its circumflex branches with a slight opacification of the distal portion of the cavernous bodies. Another study revealed the same findings after injection of contrast medium into the corpus spongiosum of the flaccid penis. 19 Contrast enhancement was visualized in the glans, the deep dorsal vein, the circumflex veins and, especially at a late stage, in the cavernous bodies. It could be proved that the corpus spongiosum and the cavernous compartments share drainage pathways and that retrograde filling of the cavernous bodies from these veins is the most likely connective route between these compartments. Furthermore, corrosion casts of the human penis show a common venous drainage of the spongy bodies and the cavernous compartments into the deep dorsal vein and its circumflex veins, particularly in the distal and midshaft portion of the penis. 25 This might be the reason for the mainly distal appearance of contrast. It stays unaffected from the existence of any stricture of the urethra or fibrosis of the spongy body.
The assumption of a retrograde drug transfer into the cavernous bodies is supported by the clinical experience that patients after radical prostatectomy with ligation of the dorsal vein complex show a higher response to intraurethrally applied PGE1. 15 Increased intracavernosal drug levels and prolongation of the erectile state are described.
11
Studies using a constriction band 19, 24 show a higher effect, with an improvement of penile rigidity and the duration of an erection sufficient for intercourse. The artificial occlusion of the proximal penile venous system facilitates retrograde drainage into the cavernous bodies.
Conclusion
Retrograde venous blood flow into the cavernous bodies seems to be the most relevant path of drug transfer after intraurethral application of PGE1. The corpus spongiosum and the cavernous compartments of the penis share common drainage pathways, particularly in the distal part of the penis. Intraurethrally applied PGE1 reaches the cavernous bodies through the deep dorsal vein and its circumflex branches. Vessels communicating directly between the corpus spongiosum and the cavernous compartments as a second possible pathway of drug transfer could not be proved by means of our methodology. Studies performing spongiosography after intraurethral or intraspongiosal application of PGE1 are needed to verify this alternative way of drug transfer.
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